These findings implicate RhoA, TSCs, and Rac1 as potential therapeutic targets for resolving capillary leakage during ANDV infection and a potential means of resolving edema during symptomatic HPS stages. The gene discussed is RAC1; the disease is Hermansky-Pudlak syndrome.